Cancer Molecular Imaging Program monthly Series featuring Dr. Weibo Cai
Image-guided drug delivery, and theranostics
- Date: February 27, 2017 4:00 PM - 5:00 PM
- Location: 13-105 CHS
Los Angeles, California 90095
Weibo Cai, Ph.D.
Radiology Medical Physics Biomedical Engineering
University of Wisconsin, Madison
Dr. Weibo Cai's research is focused on molecular imaging and image-guided drug delivery of cancer, and cardiovascular diseases with peptides, proteins, and a variety of nanomaterials. The primary imaging techniques used in these studies are positron emission tomography (PET), photoacoustic tomography (PAT), optical imaging, and magnetic resonance imaging (MRI). Some of the major molecular targets that his lab is investigating are CD105 (i.e. endoglin), PD-1/PD-L1, CTLA-4, VEGFR, CD146, integrin αvβ3, among others. The nanomaterials that will be discussed in this presentation may include silica-based nanoparticles, nano-graphene oxide, micelles, iron oxide nanoparticles, 2-D nanomaterials, hybrid nanomaterials, among many others. Lastly, the emerging paradigm of intrinsically radiolabeled nanomaterials will be discussed as multi-modal PET/MRI, PET/PAT imaging agents, as well as for theranostic applications.
Light lunch served
Sponsored by UCLA's Jonsson Comprehensive Cancer Center Cancer Molecular Imaging program